[68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market

EQS-News: Pentixapharm Holding AG / Key word(s): Market Report [68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market 09.06.2026 / 08:04 CET/CEST The issuer is solely responsible for the content of this announcement. PENTIXAPHARM HOLDING AG | Press Release

 

09.06.2026, Berlin, Germany

[⁶⁸Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market

Pentixapharm Holding AG today announced the positive feedback from the FDA (“study may proceed”) for the initiation of the Phase III PANDA study with [⁶⁸Ga]Ga-PentixaFor. Subject to successful development and regulatory approval, the company sees an annual revenue potential of over one billion US dollars for [⁶⁸Ga]Ga-PentixaFor – driven by one of the largest unmet diagnostic needs at the intersection of hypertension, endocrinology, and precision medicine.
 

Background: A Silent Mass Market and a Diagnostic Challenge

High blood pressure is one of the most common and consequential widespread diseases worldwide. In the United States alone, Center for Disease Control (CDC) data shows nearly 120 million adults are affected – approximately 48% of the adult population. More than 87 million hypertensive patients are considered treatment-resistant or uncontrolled: they take medication but continue to suffer from hypertension.

A frequently overlooked cause driving treatment resistance is Primary Hyperaldosteronism (PA). Studies show that PA is responsible for 5–10% of all hypertensive patients – corresponding to approximately 6.5–7 million individuals in the United States.

PA and its subtypes remain chronically underdiagnosed today. In particular, adrenal vein sampling (AVS) – the invasive procedure used for treatment-defining diagnostics – is technically demanding and availability is restricted. The result: most PA patients receive lifelong medical treatment, even though a subset could be permanently cured through a single surgical procedure.

Schreibe Deinen Kommentar